Mayne Pharma Group Ltd. (AU:MYX) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mayne Pharma Group Ltd. has announced the cessation of 4,408 performance rights due to unmet conditions, effective from April 4, 2024. This financial development could indicate important shifts in the company’s stock performance and internal management strategies.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.